Home / Companies / News / Pfizer-BioNTech potential Covid-19 vaccine shows promise in additional data

Pfizer-BioNTech potential Covid-19 vaccine shows promise in additional data

The companies said the data also demonstrated an induction of high level of T-cell response against the novel coronavirus

Premium

BioNtech's US shares gained 12 per cent, while Pfizer's stock rose 3.6 per cent in early trading

1 min read Last Updated : Jul 20 2020 | 7:59 PM IST

German biotech firm BioNTech and US drugmaker Pfizer on Monday reported additional data from their experimental Covid-19 vaccine that showed it was safe and induced an immune response in patients.

BioNtech's US shares gained 12 per cent, while Pfizer's stock rose 3.6 per cent in early trading.

The companies said the data also demonstrated an induction of high level of T-cell responses against the novel coronavirus.

More than 150 possible vaccines are being developed and tested around the world to try to stop the pandemic. There are 23 candidates in human clinical trials, including from Moderna and AstraZeneca Plc.

ALSO READ: Coronavirus LIVE: 4,985

Topics : Coronavirus Lockdown Community Transmission Coronavirus Vaccine Pfizer Coronavirus Tests

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in